title: G1-4A, a Polysaccharide from Tinospora cordifolia Inhibits the Survival of Mycobacterium tuberculosis by Modulating Host Immune Responses in TLR4 Dependent Manner.
abstract: Rapid emergence of drug resistance in Mycobacterium tuberculosis (MTB) is a major health concern and demands the development of novel adjunct immunotherapeutic agents capable of modulating the host immune responses in order to control the pathogen. In the present study, we sought to investigate the immunomodulatory effects of G1-4A, a polysaccharide derived from the Indian medicinal plant Tinospora cordifolia, in in-vitro and aerosol mouse models of MTB infection. G1-4A treatment of MTB infected RAW264.7 macrophages significantly induced the surface expression of MHC-II and CD-86 molecules, secretion of proinflammatory cytokines (TNF-α, IL-β, IL-6, IL-12, IFN-γ) and nitric oxide leading to reduced intracellular survival of both drug sensitive (H37Rv) as well as multi drug resistant strains (Beijing and LAM) of MTB, which was partially attributed to G1-4A induced NO production in TLR4-MyD88 dependent manner. Similarly, bacillary burden was significantly reduced in the lungs of MTB infected BALB/c mice treated with G1-4A, with simultaneous up-regulation of the expression of TNF-α, INF-γ and NOS2 in the mouse lung along with increased levels of Th1 cytokines like IFN-γ, IL-12 and decreased levels of Th2 cytokine like IL-4 in the serum. Furthermore, combination of G1-4A with Isoniazid (INH) exhibited better protection against MTB compared to that due to INH or G1-4A alone, suggesting its potential as adjunct therapy. Our results demonstrate that modulation of host immune responses by G1-4A might improve the therapeutic efficacy of existing anti-tubercular drugs and provide an attractive strategy for the development of alternative therapies to control tuberculosis.
authors.affiliation: Radiation Medicine Centre, Bhabha Atomic Research Centre, Mumbai, India.
authors.forename: Pramod Kumar
authors.initials: PK
authors.lastname: Gupta
authors.affiliation: Radiation Medicine Centre, Bhabha Atomic Research Centre, Mumbai, India.
authors.forename: Pampi
authors.initials: P
authors.lastname: Chakraborty
authors.affiliation: Tuberculosis Aerosol Challenge Facility, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
authors.forename: Santosh
authors.initials: S
authors.lastname: Kumar
authors.affiliation: Tuberculosis Aerosol Challenge Facility, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
authors.forename: Prafull Kumar
authors.initials: PK
authors.lastname: Singh
authors.affiliation: Radiation Medicine Centre, Bhabha Atomic Research Centre, Mumbai, India.
authors.forename: M G R
authors.initials: MG
authors.lastname: Rajan
authors.affiliation: Radiation Medicine Centre, Bhabha Atomic Research Centre, Mumbai, India.
authors.forename: Krishna B
authors.initials: KB
authors.lastname: Sainis
authors.affiliation: Radiation Medicine Centre, Bhabha Atomic Research Centre, Mumbai, India.
authors.forename: Savita
authors.initials: S
authors.lastname: Kulkarni
mesh_terms: D000818:Animals; D002460:Cell Line; D007113:Immunity, Innate; D008264:Macrophages / Q000276:immunology / Q000382:microbiology; D051379:Mice; D008807:Mice, Inbred BALB C; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000276:immunology; D010587:Phagocytosis; D011134:Polysaccharides / Q000302:isolation & purification / Q000494:pharmacology*; D031610:Tinospora / Q000737:chemistry*; D051197:Toll-Like Receptor 4 / Q000502:physiology*
chemical_list: D011134:Polysaccharides; C495345:TLR4 protein, human; D051197:Toll-Like Receptor 4